FdaApplication
ANDA 219221
Identifiers
- fda_app_no: ANDA219221
Properties
| Property | Value |
|---|---|
| applicant_name | RUBICON RESEARCH LTD |
| application_type | ANDA |
| approval_date | 2024-11-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IPRATROPIUM BROMIDE | IPRATROPIUM BROMIDE | 0.042MG/SPRAY | SPRAY, METERED;NASAL |
1 product